Browse by Condition in Atlanta
And 75 more conditions with trials in Atlanta
Recruiting Clinical Trials in Atlanta
NCT03191149 · Phase 2 · National Cancer Institute (NCI)
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
NCT06524544 · Phase 3 · National Cancer Institute (NCI)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
NCT07195734 · Phase 2 · National Cancer Institute (NCI)
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
NCT06205485 · Phase 3 · Canadian Cancer Trials Group
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
NCT07215624 · Wake Forest University Health Sciences
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
NCT04803201 · Phase 2 · Alliance for Clinical Trials in Oncology
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
NCT02493478 · Children's Hospital of Philadelphia
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
NCT05172960 · Edwards Lifesciences
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
NCT05236114 · Tempus AI
GEMINI-NSCLC: NSCLC Biomarker Study
NCT06526195 · Abbott Medical Devices
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06218875 · W.L.Gore & Associates
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
NCT04634240 · University of British Columbia
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Top Study Sponsors in Atlanta
| Sponsor | Recruiting studies |
|---|---|
| Emory University | 182 |
| National Cancer Institute (NCI) | 19 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 19 |
| Eli Lilly and Company | 18 |
| AstraZeneca | 13 |
| Georgia State University | 12 |
| Novartis Pharmaceuticals | 12 |
| Sanofi | 11 |
Trials in Atlanta by Phase
| Phase | Studies |
|---|---|
| Early Phase 1 | 7 |
| Phase 1 | 119 |
| Phase 1/2 | 82 |
| Phase 2 | 191 |
| Phase 2/3 | 26 |
| Phase 3 | 169 |
| Phase 4 | 41 |
| Not phased | 396 |
123 of these studies accept healthy volunteers.
Clinical Trials in Atlanta: Common Questions
How many clinical trials are recruiting in Atlanta, GA?
1031 clinical trials list a recruiting site in Atlanta, GA, across 105 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Atlanta?
The most active research areas in Atlanta right now are rheumatoid arthritis, ankylosing spondylitis, leukemia. Browse by condition above to see each study.
Who sponsors clinical trials in Atlanta?
The sponsors with the most recruiting studies in Atlanta include Emory University, National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID).
Are there clinical trials for healthy volunteers in Atlanta?
Yes. 123 of the recruiting studies in Atlanta accept healthy volunteers.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Atlanta, GA
Atlanta, GA is home to 1031 actively recruiting clinical trials across 105 medical conditions as of 2026. The most active research areas include rheumatoid arthritis, ankylosing spondylitis, leukemia. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.